Synthesis and Characterization of New 1‐(4‐Methylpiperazin‐1‐yl)thioureas as Potential Antitubercular Agents
- 5 November 2015
- journal article
- research article
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 54 (1) , 720-727
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapiesThe Lancet Respiratory Medicine, 2015
- Global Epidemiology of TuberculosisCold Spring Harbor Perspectives in Medicine, 2014
- Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisThe Lancet Respiratory Medicine, 2014
- Advances in the development of new tuberculosis drugs and treatment regimensNature Reviews Drug Discovery, 2013
- Nitroimidazoles for the Treatment of TB: Past, Present and FutureFuture Medicinal Chemistry, 2011
- Tmc207: the First Compound of A New class of Potent Anti-Tuberculosis DrugsFuture Microbiology, 2010
- Potential of Rapid Diagnosis for Controlling Drug-Susceptible and Drug-Resistant Tuberculosis in Communities Where Mycobacterium tuberculosis Infections Are Highly PrevalentJournal of Clinical Microbiology, 2009
- 1,5-Diphenylpyrrole Derivatives as Antimycobacterial Agents. Probing the Influence on Antimycobacterial Activity of Lipophilic Substituents at the Phenyl RingsJournal of Medicinal Chemistry, 2008
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaThe Lancet, 2006
- Synthesis of 4‐hydroxyquinolin‐2(1H)‐one analogues and 2‐substituted quinolone derivativesJournal of Heterocyclic Chemistry, 2001